posted on 2024-09-16, 17:12authored byJosemarco Mendoza-Avila, Volker Döring, Madeleine Bouzon, Ivan Dubois, Tanja Knaus, Louis M. M. Mouterde, Anne Zaparucha, Francesco G. Mutti, Carine Vergne-Vaxelaire
The
biocatalytic synthesis of chiral amines from carbonyl
compounds
and ammonia is a major advance in sustainable synthetic chemistry.
Using whole cells for bioamination reactions is advantageous given
their low preparation cost and direct applicability; however, amine
toxicity limits the reaction when living cells are used. Herein, we
adapted Escherichia coli BL21(DE3)
cells to grow in the presence of 100 mM hexan-2-amine via directed evolution in continuous culture, obtaining six times more
tolerant strains than the wild-type. The adapted strains also displayed
superior tolerance for structurally different amines. Coexpression
of genes encoding for amine dehydrogenase (AmDH) and formate dehydrogenase
activities in the adapted strains enabled the stereoselective bioamination
(ee > 99%) of different prochiral ketones with up to 80% conversion
at high substrate loading (up to 200 mM) without exogenous cofactor
addition. The adapted cells displayed longer survival and higher population
density during the reactions. The present biotechnological E. coli system contributes to the development of
more robust biocatalysis for amine production.